12
Hanmi Pharma
128940.KQ·KOSDAQSeoul KRFounded 19733,000 employees
Mid CappharmaPublicMetabolicOncology
Platform: HM15211 TriAg
Market Cap
$3B
All Drugs
3
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (128940.KQ)
Loading 128940.KQ stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 128-2997 | 128-2997 | Phase 1/2 | 1 | VEGF | CFHS | ||
| Zoriderotide | 128-1138 | Phase 3 | 2 | EZH2 | T2D | ||
| Gozecilimab | 128-7453 | Phase 2 | 2 | SMN2 | RSVET |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
Hanmi Pharma trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)